CEL-SCI CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
CEL-SCI CORPORATION (CVM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 7.81 thousand shares for the 1-month period ending 2024-04-19, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2025-08-14
- 2024-04-19: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 1 month 7.81K shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 1 month as first filed 234.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 1 month as first filed |
|---|---|---|
| 2024-04-19 | 7.81K shares 10-Q · filed 2025-08-14 | 234.33K shares 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |